Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SWB:GU5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SWB:GU5
|
CN |
|
E
|
Evonik Industries AG
DUS:EVK
|
DE |
|
A
|
ASMPT Ltd
F:AY7A
|
SG |
|
Future Fintech Group Inc
NASDAQ:FTFT
|
CN |
|
S
|
Shanghai Fudan Microelectronics Group Co Ltd
F:FUD
|
CN |
|
H
|
Hyundai Engineering & Construction Co Ltd
KRX:000720
|
KR |
Dividends
Dividend Yield
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
GU5 have increased by 31%.
Payout Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for GU5 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
GU5 Price
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
| Average Annual Return | 1.16% |
| Standard Deviation of Annual Returns | 33.75% |
| Max Drawdown | -100% |
| Market Capitalization | 32.3B EUR |
| Shares Outstanding | 2 630 793 958 |
| Percentage of Shares Shorted |
N/A
|
